Perrigo (NYSE:PRGO) Raised to Strong-Buy at Wall Street Zen

Perrigo (NYSE:PRGOGet Free Report) was upgraded by investment analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report released on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings raised shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $19.33.

Read Our Latest Stock Analysis on PRGO

Perrigo Stock Performance

Shares of PRGO opened at $13.59 on Friday. The stock’s 50-day simple moving average is $12.62 and its 200 day simple moving average is $11.40. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.55 and a beta of 0.59. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.32 and a current ratio of 2.32. Perrigo has a 52-week low of $9.23 and a 52-week high of $22.65.

Perrigo (NYSE:PRGOGet Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the firm earned ($0.06) EPS. The company’s quarterly revenue was down 3.1% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Research analysts forecast that Perrigo will post 2.18 EPS for the current fiscal year.

Institutional Investors Weigh In On Perrigo

Hedge funds have recently added to or reduced their stakes in the company. Thompson Siegel & Walmsley LLC increased its position in shares of Perrigo by 28.4% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 4,658,601 shares of the company’s stock valued at $64,848,000 after purchasing an additional 1,029,770 shares during the last quarter. Cooke & Bieler LP lifted its position in Perrigo by 0.9% in the 4th quarter. Cooke & Bieler LP now owns 3,714,313 shares of the company’s stock worth $51,703,000 after buying an additional 33,902 shares during the last quarter. Norges Bank bought a new stake in Perrigo in the 4th quarter worth approximately $42,607,000. Bank of America Corp DE boosted its stake in Perrigo by 25.5% in the first quarter. Bank of America Corp DE now owns 1,568,598 shares of the company’s stock worth $16,847,000 after buying an additional 318,248 shares in the last quarter. Finally, Sound Income Strategies LLC boosted its stake in Perrigo by 34.0% in the first quarter. Sound Income Strategies LLC now owns 1,525,384 shares of the company’s stock worth $16,779,000 after buying an additional 387,027 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Perrigo Company Profile

(Get Free Report)

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter (OTC) products and other nonprescription health and wellness products. Its portfolio spans consumer health categories including pain relief, allergy and cold remedies, digestive health, skin care, oral care, vitamins and supplements, and women’s health.

The company sells products under both its own brands and retailer-owned store brands through pharmacies, supermarkets, mass merchants, e-commerce channels and other outlets.

Featured Stories

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.